Form D · Other Health Care
DermTech, Inc.
La Jolla, CA · CIK 0001518913
Offering snapshot reported Feb 7, 2018 · SEC filing
- Reported sold
- $10M Offering amount: $15.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$9,597,097 → $10,007,079
- Reported investors15 → 16
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2018 | Amendment | $10,007,079 | $409,982vs Dec 5, 2017 | 16 | SEC filing |
| Dec 5, 2017 | Amendment | $9,597,097 | $2,524,145vs Jun 30, 2017 | 15 | SEC filing |
| Jun 30, 2017 | Amendment | $7,072,952 | $3,953,705vs Dec 13, 2016 | 12 | SEC filing |
| Dec 13, 2016 | Amendment | $3,119,247 | $1,052,971vs Oct 21, 2016 | 5 | SEC filing |
| Oct 21, 2016 | Initial | $2,066,276 | No comparison | 3 | SEC filing |
| Nov 12, 2015 | Amendment | $4,314,872 | $2,547,292vs Sep 11, 2015 | 8 | SEC filing |
| Sep 11, 2015 | Amendment | $1,767,580 | $995,265vs Aug 26, 2015 | 4 | SEC filing |
| Aug 26, 2015 | Amendment | $772,315 | $188,672vs Aug 14, 2015 | 2 | SEC filing |
| Aug 14, 2015 | Initial | $583,643 | No comparison | 2 | SEC filing |
| Apr 15, 2015 | Initial | $2,441,068 | No comparison | 16 | SEC filing |
| Aug 16, 2013 | Initial | $5,774,985 | No comparison | 30 | SEC filing |
| Apr 11, 2012 | Initial | $11,158,700 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $446K
- Finders' fees
- $0
- Form D file number
- 021-273021
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Paulson Investment Company LLC | 5670 |
Source: Form D, filed Feb 7, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Dobak, M.D. | Director, Executive |
| Gary Jacobs | Director, Executive |
| Steven Kemper | Executive |
| Scott Pancoast | Director |
| Carl Peck, M.D. | Director |
| Gene Salkind, M.D. | Director |
| Michael Willis | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11099 N. Torrey Pines Road Suite 100
La Jolla, CA, 92037
La Jolla, CA, 92037